These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6545595)

  • 21. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Individualization of carriers of Duchenne's muscular dystrophy . Problems and prospectives].
    Comi G; Comola M; Galardi G; Piattoni F; Erembourg L; Canal N
    Minerva Pediatr; 1986 Aug; 38(15-16):625-32. PubMed ID: 3796511
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are reference limits for serum creatine kinase valid in detection of the carrier state for Duchenne muscular dystrophy?
    Gruemer HD; Miller WG; Chinchilli VM; Leshner RT; Hassler CR; Blasco PA; Nance WE; Goldsmith BM
    Clin Chem; 1984 May; 30(5):724-30. PubMed ID: 6713632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carrier testing in families of isolated cases of duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity.
    Nicholson GA; Lane RJ; Gardner-Medwin D; Walton JN
    J Neurol Sci; 1981 Jul; 51(1):29-42. PubMed ID: 7252519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fluctuation of serum myoglobin levels in Duchenne muscular dystrophy and the carrier.
    Konagaya M; Takayanagi T; Konagaya Y; Sobue I
    J Neurol Sci; 1982 Sep; 55(3):259-65. PubMed ID: 6890096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum creatine kinase and sulphydryl concentration after ischemic forearm work in patients and carriers of Duchenne's progressive muscular dystrophy].
    Moser H; Wiesmann U
    Klin Wochenschr; 1971 Apr; 49(8):488-94. PubMed ID: 5574169
    [No Abstract]   [Full Text] [Related]  

  • 33. [Present-day clinico-genetic framework of Duchenne's muscular dystrophy].
    Meola G
    Riv Neurol; 1989; 59(1):8-14. PubMed ID: 2669113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
    Kato F; Takahashi K
    Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
    [No Abstract]   [Full Text] [Related]  

  • 35. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of creatine kinase activity using bioluminescence].
    Kühn HJ; Theml P; Pilz D
    Psychiatr Neurol Med Psychol (Leipz); 1984 Sep; 36(9):551-5. PubMed ID: 6514867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Duchenne muscular dystrophy: detection of carriers using ultrasound].
    Rott HD; Mulz D
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1678-81. PubMed ID: 7140545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum enzymes in disease of skeletal muscle.
    Rosalki SB
    Clin Lab Med; 1989 Dec; 9(4):767-81. PubMed ID: 2686911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid-CPK test. A new diagnostic aid for muscular dystrophy and its carriers?
    Sen S; Das PK
    Eur Neurol; 1978; 17(5):258-64. PubMed ID: 710453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum LDH-5 in carriers of Duchenne muscular dystrophy.
    Burt D; Emery AE
    Neurology; 1979 Feb; 29(2):239-41. PubMed ID: 571069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.